Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | BTN3A1 | O00481 | 3/20 | 0.35 |
| ▸ | MVD | P53602 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2351336 | 0.97 | FDPS (0.50) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL28494654 | 0.85 | FDPS (0.64) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL45357 | 0.85 | FDPS (0.64) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL36089 | 0.85 | FDPS (0.64) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL897837 | 0.85 | FDPS (0.64) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL28767268 | 0.85 | FDPS (0.64) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL140392 | 0.85 | FDPS (0.64) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL554667 | 0.85 | FDPS (0.64) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL8851949 | 0.85 | FDPS (0.64) | FDPSBLMTDP1BTN3A1MVD | |
| Triphosphate SCHEMBL28334675 | 0.85 | FDPS (0.64) | FDPSBLMTDP1BTN3A1MVD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4531867-B2 | — | — | 2010-08-25 | — | — | JP | claimed |
| EP-1450820-A4 | METHOD FOR TREATING OR PREVENTING INFLAMMATORY DISEASES | INSPIRE PHARMACEUTICALS INC (US) | 2009-02-18 | — | — | EP | claimed |
| EP-1450820-A2 | METHOD FOR TREATING OR PREVENTING INFLAMMATORY DISEASES | Inspire Pharmaceuticals, Inc. (US) | 2004-09-01 | — | — | EP | claimed |
| US-6596725-B2 | Vision defects | INSPIRE PHARMACEUTICALS, INC. | 2003-07-22 | — | — | US | claimed |
| US-20030125299-A1 | Method for treating or preventing inflammatory diseases | PETERSON WARD M (US) | 2003-07-03 | — | — | US | claimed |
| WO-2003039473-A2 | METHOD FOR TREATING OR PREVENTING INFLAMMATORY DISEASES | INSPIRE PHARMACEUTICALS, INC. (US) | 2003-05-15 | — | — | WO | claimed |
| EP-0981534-A2 | DINUCLEOTIDES AND THEIR USES | Inspire Pharmaceuticals, Inc. (US) | 2000-03-01 | — | — | EP | claimed |
| WO-1998034942-A2 | DINUCLEOTIDES AND THEIR USE | INSPIRE PHARMACEUTICALS, INC. (US) | 1998-08-13 | — | — | WO | claimed |
| US-8008274-B2 | P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis | INSPIRE PHARMACEUTICALS, INC. (US) | 2011-08-30 | — | — | US | disclosed |
| EP-1450820-A4 | METHOD FOR TREATING OR PREVENTING INFLAMMATORY DISEASES | INSPIRE PHARMACEUTICALS INC (US) | 2009-02-18 | — | — | EP | disclosed |
| EP-1450820-A2 | METHOD FOR TREATING OR PREVENTING INFLAMMATORY DISEASES | Inspire Pharmaceuticals, Inc. (US) | 2004-09-01 | — | — | EP | disclosed |
| US-20030125299-A1 | Method for treating or preventing inflammatory diseases | PETERSON WARD M (US) | 2003-07-03 | — | — | US | disclosed |
| WO-2003039473-A2 | METHOD FOR TREATING OR PREVENTING INFLAMMATORY DISEASES | INSPIRE PHARMACEUTICALS, INC. (US) | 2003-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030125299-A1 | Method for treating or preventing inflammatory diseases | ADORA2B, ADORA2A, P2RY2 | FDPS 932/4885BLM 610/4885TDP1 2675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.